Jason Karlawish (PARC Research Associate) was featured in The New York Times and Vox about a new Alzheimer's Disease drug and questions surrounding its benefits and risks.
Jason Karlawish quoted in The New York Times and Vox
Jason Karlawish (PARC Research Associate) was featured in The New York Times and Vox about a new Alzheimer's Disease drug and questions surrounding its benefits and risks.